Table of Contents
Charcot-Marie-Tooth disease (CMT) affects 1 in 2500 people and more than 30 gene mutations play a causative role. It is the eponym for heritable peripheral neuropathy and is named for 3 investigators in the late 1800s. Different forms of CMT exist and the classification is still not completely ruled out. Mutations of the inverted formin-2 gene (INF-2) were identified in patients with focal segmental glomerulosclerosis[1] (FSGS) and autosomal dominant intermediate Charcot-Marie Tooth (DI-CMT) disease. A novel unclassified variante, c.2659GA; p.E887K(het.), located on chromosome 14q32.33, was identified in a 21 months old child with unknown peripheral neuropathy and muscular weakness. The mutation leads to a change of amino acid glutamate to lysine in position 887. This variante was not described yet in world literature.
Hydranencephaly is an extremely rare anomaly of cerebral structures that occurs in-utero. Cerebral hemispheres are destroyed with transformation into a membranous sac with cerebrospinal fluid and parts of cortex and white matter. The disorder has an incidence of 0.2% in children. Clinical symptoms in neonates are seizures, respiratory failure, flaccidity or decerebrate posturing. Complete absence of the cerebral hemispheres and falx are present. We present a case of a male newborn with hydranencephaly. A possible correlation with in utero exposure to vasoactive drugs will be discussed.